Agenus | AGEN - Eigenkapital Und Reserven





Eigenkapital Und Reserven Veränderung Datum
AbbVie USD -3.27B 628M 2025-12
Agenus USD -271.11M 3.03M 2025-12
Amgen USD 8.66B 961M 2025-12
AstraZeneca USD 48.67B 2.78B 2025-12
Bristol-Myers Squibb USD 18.55B 1.06B 2025-09
Celldex Therapeutics USD 527.16M 71.2M 2025-12
CSL USD 18.66B 2.75B 2025-12
Eli Lilly USD 26.54B 2.74B 2025-12
Gilead Sciences USD 22.62B 1.16B 2025-12
GlaxoSmithKline GBP 16.38B 229M 2025-12
Glaxosmithkline GBP 22.06B 360M 2025-12
Incyte USD 5.17B 516.28M 2025-12
Intrexon USD 43.17M 75.33M 2024-06
J&J USD 78.47B 0 2025-09
Jiangsu Hengrui CNY 59.5B 814.63M 2025-09
Karyopharm Therapeutics USD -269.26M 30.33M 2025-09
MacroGenics USD 55.59M 11.41M 2025-12
Merck EUR 28.59B 344M 2025-12
Merck USD 51.85B 2.79B 2025-09
Northwest Biotherapeutics USD -108.65M 8.26M 2025-09
Novartis USD 46.13B 1.38B 2025-12
Novavax USD -127.75M 28.92M 2025-12
Pfizer USD 92.8B 4.11B 2025-09
Regeneron Pharmaceuticals USD 31.26B 299.1M 2025-12
Rigel Pharmaceuticals USD 117.61M 35.67M 2025-09
Sangamo BioSciences USD 19.6M 14.7M 2025-06
Veracyte USD 1.26B 36.61M 2025-09